Effect of Simethicone to length of stay in gynecologic patient, Thai

Phase 4

Completed

• Conditions: age 18 years or moreelective laparotomy in benign gynecologic surgery; simethicone; length of stay; benign gynecologic surgery; ERAS

• Registration Number: TCTR20210204012
• Lead Sponsor: Kanchanok Taemamu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-04
• Study Completion: 2021-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 182

Inclusion Criteria

elective laparotomy for benign gynecologic surgery
willing to enroll

Exclusion Criteria

simethicone allergy
emergency surgery
unwilling to enrolled

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
length of stay 3days days

Secondary Outcome Measures

Name	Time	Method
Factors associated length of stay 3days Blood loss,side effector Simeticone 3days GI symptoms,patient satisfaction 3days ask patients rate of satisfaction from 1 to 10